By:Dr. Menghis Bairu
Date:February 05, 2024
It was such an honor for our TWIN group delegation to visit Dr Sabin Nsanzimana, Minister of Health, #Rwanda. I shared briefly our Rwanda based #BioUsawa #Biotechnology Ltd newco vision to manufacture lifesaving, quality, affordable monoclonal antibodies for patients in Africa and beyond. Looking forward to strengthening our partnership and provide access to safe and effective medicines (#SDG 3) for all. ——————— “When patients die because there is no cure, it's a tragedy; When patients die even when there is an effective cure because of the cost, it is injustice.” http://biousawa.com/ @nsanzimanasabin #Rwanda #SDG3#healthequity #cancercare #Africa#AfricaCDC #LeaveNoOneBehind
During the COECSA Congress, Bio Usawa’s leadership team paid a courtesy visit to the Director General of the Ethiopian Food and Drug Authority (EFDA), M…
August 2025Bio Usawa’s Chief Executive Officer, Dr. Menghis, and Chief Operating Officer, Dr. Patrick Lukulay, held a strategic meeting with the Africa CDC’s Local…
August 2025Exciting developments in Anti-VEGF therapy are afoot! Anti-VEGF is the gold standard for managing: • Diabetic Macular Edema (DME) • Wet Age-rela…
August 2025